If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSenior Share News (SNR)

Share Price Information for Senior (SNR)

Share Price is delayed by 15 minutes
Get Live Data
288.50    0.00 (0.00%)
Bid:
288.50
Ask:
289.00
Spread: 0.50 (0.173%)
Market Cap: £1.19b
SNR Live PriceLast checked at - London Stock Exchange

Intraday Senior Share Chart

Friday broker round-up

Fri, 20th Dec 2019 12:28
(Sharecast News) - Segro: HSBC downgrades to hold with a target price of 869p.

Purplebricks: Peel Hunt reiterates add with a target price of 130p.

Diageo: Credit Suisse reiterates outperform with a target price of 3,570p.

Synthomer: Deutsche Bank reiterates buy with a target price of 410p.

AstraZeneca: Barclays reiterates overweight with a target price 8,300p.

GlaxoSmithKline: Barclays reiterates equal weight with a target price of 1,650p.

Reckitt Benckiser Group: Goldman Sachs reiterates neutral with a target price 6,300p.

Halma: Jefferies reiterates hold with a target price of 2,040p.

TUI: HSBC reiterates hold with a target price of 1,040p.

Senior: JP Morgan reiterates hold with a target price of 180p.

Related News

WINNERS & LOSERS: RC365 jumps on partnership; Craneware slides
2 days ago

WINNERS & LOSERS: RC365 jumps on partnership; Craneware slides

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday.

LONDON MARKET CLOSE: FTSE 100 up as US jobs data eases rate hike fears
3 days ago

LONDON MARKET CLOSE: FTSE 100 up as US jobs data eases rate hike fears

(Alliance News) - European stocks soared on Thursday as weaker than expected US jobs figures dampened market worries of a near-term interest rate hike...

Hutchmed drug approved in China for advanced gastric cancer
3 days ago

Hutchmed drug approved in China for advanced gastric cancer

(Alliance News) - Hutchmed China Ltd on Thursday announced regulatory approval for savolitinib, brand name 'ORPATHYS', for a form of gastric cancer wi...

Senior News

Senior sees full-year trading "comfortably" beating its expectations
22 Apr 2026

Senior sees full-year trading "comfortably" beating its expectations

(Alliance News) - Senior PLC on Wednesday guided full-year performance ahead of its prior expectations, as it reported a "good start" to 2026 trading....

UK's Intertek rejects $11 billion buyout proposal from EQT
16 Apr 2026

UK's Intertek rejects $11 billion buyout proposal from EQT

* Intertek rejects ⁠EQT's 51.5 pound per share takeover bid

Advent International rules out making competing offer for Senior
8 Apr 2026

Advent International rules out making competing offer for Senior

(Alliance News) - Advent International LP on Wednesday said it does not intend to make a bid for Senior PLC, clearing the way for an agreed deal with ...

Advent not planning to bid for Senior
8 Apr 2026

Advent not planning to bid for Senior

(Sharecast News) - Advent said on Wednesday that it does not plan to make a bid for Senior, after the engineer agreed to be bought by Tinicum and Blac...